<?xml version="1.0" encoding="UTF-8"?>
<p>Herb–drug interactions can reflect a number of mechanisms, including synergistic or antagonistic effects with conventional drugs being used by the patient. For example, oncology patients are often treated with anticoagulant medications as a result of venous thrombosis, thought to be caused by the release of procoagulant factors by the tumor (Trousseau’s syndrome). Many herbal products contain compounds which have anticoagulant and/or antiplatelet properties, significantly increasing the risk for spontaneous bleeding in these patients [
 <xref rid="B35-pharmaceuticals-13-00455" ref-type="bibr">35</xref>]. Another example is medicinal mushrooms, which are popular among oncology patients and whose polysaccharides have been shown to reduce glucose levels and complications of diabetes mellitus [
 <xref rid="B36-pharmaceuticals-13-00455" ref-type="bibr">36</xref>]. However, medicinal mushrooms such as reishi (
 <italic>Ganoderma lucidum</italic>) and maitake (
 <italic>Grifola fondosa)</italic> have been associated with hypoglycemia in patients treated with antidiabetic drugs [
 <xref rid="B37-pharmaceuticals-13-00455" ref-type="bibr">37</xref>,
 <xref rid="B38-pharmaceuticals-13-00455" ref-type="bibr">38</xref>].
</p>
